Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moleculin Biotech (MBRX) Other Non-Current Assets (2025)

Moleculin Biotech's Other Non-Current Assets history spans 1 years, with the latest figure at $900000.0 for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $900000.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $900000.0 (changed N/A YoY), and the annual figure for FY2025 was $900000.0, changed.
  • Other Non-Current Assets for Q4 2025 was $900000.0 at Moleculin Biotech, roughly flat from $900000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $900000.0 in Q2 2025 to a low of $900000.0 in Q2 2025.